Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kura Oncology, Inc. (KURA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kura Oncology, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1422143.
Total stock buying since 2015: $6,361,671.
Total stock sales since 2015: $22,569,498.
Total stock option exercises since 2015: $3,595,090.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 50,000 | $303,223 | 48,558 | $379,681 | 22,682 | $143,350 |
| 2024 | 0 | $0 | 111,517 | $2,235,732 | 91,052 | $498,509 |
| 2023 | 50,000 | $575,000 | 14,500 | $201,301 | 0 | $0 |
| 2022 | 0 | $0 | 2,100 | $31,964 | 0 | $0 |
| 2021 | 0 | $0 | 6,250 | $183,950 | 6,250 | $121,437 |
| 2020 | 0 | $0 | 639,729 | $18,806,898 | 270,046 | $2,437,770 |
| 2019 | 0 | $0 | 18,000 | $379,908 | 18,000 | $110,700 |
| 2018 | 374,332 | $5,083,448 | 26,520 | $350,064 | 26,041 | $124,996 |
| 2017 | 0 | $0 | 0 | $0 | 32,985 | $158,328 |
| 2015 | 50,000 | $400,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 50,000 | $303,223 | 0 | $0 | 0 | $0 |
| 2025-05 | 0 | $0 | 3,117 | $19,069 | 0 | $0 |
| 2025-03 | 0 | $0 | 22,682 | $181,456 | 22,682 | $143,350 |
| 2025-01 | 0 | $0 | 22,759 | $179,156 | 0 | $0 |
| 2024-05 | 0 | $0 | 2,615 | $57,917 | 0 | $0 |
| 2024-01 | 0 | $0 | 108,902 | $2,177,815 | 91,052 | $498,509 |
| 2023-06 | 50,000 | $575,000 | 0 | $0 | 0 | $0 |
| 2023-01 | 0 | $0 | 14,500 | $201,301 | 0 | $0 |
| 2022-11 | 0 | $0 | 2,100 | $31,964 | 0 | $0 |
| 2021-03 | 0 | $0 | 6,250 | $183,950 | 6,250 | $121,437 |
| 2020-12 | 0 | $0 | 9,375 | $380,662 | 21,230 | $255,064 |
| 2020-11 | 0 | $0 | 6,250 | $246,437 | 6,250 | $121,437 |
| 2020-10 | 0 | $0 | 261,692 | $8,792,842 | 54,956 | $337,978 |
| 2020-09 | 0 | $0 | 237,456 | $6,637,797 | 87,456 | $1,025,552 |
| 2020-08 | 0 | $0 | 124,956 | $2,749,160 | 72,058 | $543,914 |
| 2020-02 | 0 | $0 | 0 | $0 | 28,096 | $153,825 |
| 2019-07 | 0 | $0 | 18,000 | $379,908 | 18,000 | $110,700 |
| 2018-12 | 374,332 | $5,083,448 | 26,520 | $350,064 | 0 | $0 |
| 2018-11 | 0 | $0 | 0 | $0 | 26,041 | $124,996 |
| 2017-08 | 0 | $0 | 0 | $0 | 27,985 | $134,328 |
| 2017-04 | 0 | $0 | 0 | $0 | 5,000 | $24,000 |
| 2015-11 | 50,000 | $400,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-13 | Wilson Troy Edward (President and CEO) | Buy | 13,494 | 6.64 | 89,627 |
| 2025-08-12 | Wilson Troy Edward (President and CEO) | Buy | 36,506 | 5.85 | 213,596 |
| 2025-05-19 | Bair Teresa Brophy (Chief Legal Officer) | Sale | 1,559 | 5.96 | 9,291 |
| 2025-05-19 | Ford Kathleen (Chief Operating Officer) | Sale | 1,558 | 6.28 | 9,778 |
| 2025-03-21 | Hasnain Faheem | Sale | 22,682 | 8.00 | 181,456 |
| 2025-03-21 | Hasnain Faheem | Option Ex | 22,682 | 6.32 | 143,350 |
| 2025-01-28 | Burrows Francis (Chief Scientific Officer) | Sale | 2,166 | 7.87 | 17,050 |
| 2025-01-28 | Leoni Mollie (Chief Medical Officer) | Sale | 4,963 | 7.87 | 39,068 |
| 2025-01-28 | Powl Brian T. (Chief Commercial Officer) | Sale | 1,583 | 7.87 | 12,461 |
| 2025-01-28 | Doyle Thomas James (SVP, Finance & Accounting) | Sale | 4,949 | 7.87 | 38,958 |
| 2025-01-28 | Bair Teresa Brophy (Chief Legal Officer) | Sale | 7,281 | 7.87 | 57,316 |
| 2025-01-28 | Ford Kathleen (Chief Operating Officer) | Sale | 1,817 | 7.87 | 14,303 |
| 2024-05-20 | Bair Teresa Brophy (Chief Legal Officer) | Sale | 2,615 | 22.15 | 57,917 |
| 2024-01-30 | Dale Stephen (Chief Medical Officer) | Sale | 4,825 | 21.55 | 103,978 |
| 2024-01-29 | Doyle Thomas James (SVP, Finance & Accounting) | Sale | 2,318 | 17.80 | 41,262 |
| 2024-01-29 | Dale Stephen (Chief Medical Officer) | Sale | 7,158 | 17.80 | 127,419 |
| 2024-01-29 | Bair Teresa Brophy (Chief Legal Officer) | Sale | 2,053 | 17.80 | 36,545 |
| 2024-01-29 | Ford Kathleen (Chief Operating Officer) | Sale | 1,496 | 17.80 | 26,630 |
| 2024-01-24 | Wilson Troy Edward (President and CEO) | Sale | 91,052 | 20.23 | 1,841,981 |
| 2024-01-24 | Wilson Troy Edward (President and CEO) | Option Ex | 91,052 | 5.47 | 498,509 |
| 2023-06-16 | Malley Thomas (Director) | Buy | 50,000 | 11.50 | 575,000 |
| 2023-01-27 | Doyle Thomas James (SVP, Finance & Accounting) | Sale | 1,548 | 13.89 | 21,501 |
| 2023-01-27 | Dale Stephen (Chief Medical Officer) | Sale | 9,225 | 13.88 | 128,033 |
| 2023-01-27 | Flowers Kirsten (CCO & Chief Strategy Officer) | Sale | 1,906 | 13.89 | 26,474 |
| 2023-01-27 | Ford Kathleen (Chief Operating Officer) | Sale | 1,821 | 13.89 | 25,293 |
| 2022-11-17 | Bair Teresa Brophy (Chief Legal Officer) | Sale | 2,100 | 15.22 | 31,964 |
| 2021-03-15 | Ford Kathleen (Chief Operating Officer) | Sale | 6,250 | 29.43 | 183,950 |
| 2021-03-15 | Ford Kathleen (Chief Operating Officer) | Option Ex | 6,250 | 19.43 | 121,437 |
| 2020-12-15 | Ford Kathleen (Chief Operating Officer) | Sale | 9,375 | 40.60 | 380,662 |
| 2020-12-15 | Ford Kathleen (Chief Operating Officer) | Option Ex | 9,375 | 19.43 | 182,156 |
| 2020-12-01 | Wilson Troy Edward (President and CEO) | Option Ex | 11,855 | 6.15 | 72,908 |
| 2020-11-10 | Ford Kathleen (Chief Operating Officer) | Sale | 6,250 | 39.43 | 246,437 |
| 2020-11-10 | Ford Kathleen (Chief Operating Officer) | Option Ex | 6,250 | 19.43 | 121,437 |
| 2020-10-08 | Wilson Troy Edward (President and CEO) | Sale | 157,106 | 34.00 | 5,341,604 |
| 2020-10-08 | Wilson Troy Edward (President and CEO) | Option Ex | 50,370 | 6.15 | 309,775 |
| 2020-10-07 | Wilson Troy Edward (President and CEO) | Sale | 104,486 | 33.00 | 3,448,038 |
| 2020-10-07 | Wilson Troy Edward (President and CEO) | Option Ex | 4,586 | 6.15 | 28,203 |
| 2020-10-06 | Wilson Troy Edward (President and CEO) | Sale | 100 | 32.00 | 3,200 |
| 2020-09-15 | Ford Kathleen (Chief Operating Officer) | Sale | 6,250 | 29.43 | 183,937 |
| 2020-09-15 | Ford Kathleen (Chief Operating Officer) | Option Ex | 6,250 | 19.43 | 121,437 |
| 2020-09-14 | Ford Kathleen (Chief Operating Officer) | Sale | 6,250 | 29.43 | 183,937 |
| 2020-09-14 | Ford Kathleen (Chief Operating Officer) | Option Ex | 6,250 | 19.43 | 121,437 |
| 2020-09-14 | Grasso Marc (CFO, CBO) | Sale | 10,000 | 29.00 | 290,000 |
| 2020-09-14 | Grasso Marc (CFO, CBO) | Option Ex | 10,000 | 29.00 | 290,000 |
| 2020-09-14 | Wilson Troy Edward (President and CEO) | Sale | 98,490 | 28.82 | 2,838,875 |
| 2020-09-11 | Wilson Troy Edward (President and CEO) | Sale | 18,411 | 28.00 | 515,508 |
| 2020-09-11 | Wilson Troy Edward (President and CEO) | Option Ex | 17,926 | 6.15 | 110,244 |
| 2020-09-10 | Wilson Troy Edward (President and CEO) | Sale | 38,055 | 28.00 | 1,065,540 |
| 2020-09-10 | Wilson Troy Edward (President and CEO) | Option Ex | 37,030 | 6.15 | 227,734 |
| 2020-09-08 | Grasso Marc (CFO, CBO) | Sale | 10,000 | 26.00 | 260,000 |
| 2020-09-08 | Grasso Marc (CFO, CBO) | Option Ex | 10,000 | 15.47 | 154,700 |
| 2020-09-08 | Wilson Troy Edward (President and CEO) | Sale | 50,000 | 26.00 | 1,300,000 |
| 2020-08-25 | Grasso Marc (CFO, CBO) | Sale | 10,000 | 23.00 | 230,000 |
| 2020-08-25 | Grasso Marc (CFO, CBO) | Option Ex | 10,000 | 15.47 | 154,700 |
| 2020-08-25 | Wilson Troy Edward (President and CEO) | Sale | 23,053 | 22.37 | 515,787 |
| 2020-08-25 | Wilson Troy Edward (President and CEO) | Option Ex | 23,053 | 5.47 | 126,215 |
| 2020-08-24 | Wilson Troy Edward (President and CEO) | Sale | 6,568 | 22.04 | 144,771 |
| 2020-08-24 | Wilson Troy Edward (President and CEO) | Option Ex | 6,568 | 4.80 | 31,526 |
| 2020-08-19 | Wilson Troy Edward (President and CEO) | Sale | 11,913 | 22.09 | 263,193 |
| 2020-08-19 | Wilson Troy Edward (President and CEO) | Option Ex | 11,913 | 4.80 | 57,182 |
| 2020-08-18 | Wilson Troy Edward (President and CEO) | Sale | 521 | 22.00 | 11,462 |
| 2020-08-18 | Wilson Troy Edward (President and CEO) | Option Ex | 521 | 4.80 | 2,500 |
| 2020-08-17 | Wilson Troy Edward (President and CEO) | Sale | 62,901 | 22.00 | 1,383,947 |
| 2020-08-17 | Wilson Troy Edward (President and CEO) | Option Ex | 12,901 | 4.80 | 61,924 |
| 2020-08-07 | Grasso Marc (CFO, CBO) | Sale | 10,000 | 20.00 | 200,000 |
| 2020-08-07 | Grasso Marc (CFO, CBO) | Option Ex | 7,102 | 15.47 | 109,867 |
| 2020-02-11 | Wilson Troy Edward (President and CEO) | Option Ex | 28,096 | 5.47 | 153,825 |
| 2019-07-10 | Gualberto Antonio (Head of Development & CMO) | Sale | 18,000 | 21.11 | 379,908 |
| 2019-07-10 | Gualberto Antonio (Head of Development & CMO) | Option Ex | 18,000 | 6.15 | 110,700 |
| 2018-12-21 | Ecor1 Capital Fund Qualified, L.p. | Buy | 83,540 | 13.16 | 1,099,386 |
| 2018-12-19 | Ecor1 Capital Fund Qualified, L.p. | Buy | 51,879 | 13.84 | 718,005 |
| 2018-12-18 | Ecor1 Capital Fund Qualified, L.p. | Buy | 78,469 | 13.82 | 1,084,441 |
| 2018-12-17 | Ecor1 Capital Fund Qualified, L.p. | Sale | 26,520 | 13.20 | 350,064 |
| 2018-12-13 | Ecor1 Capital Fund Qualified, L.p. | Buy | 25,217 | 13.89 | 350,264 |
| 2018-12-11 | Ecor1 Capital Fund Qualified, L.p. | Buy | 15,321 | 13.91 | 213,099 |
| 2018-12-06 | Ecor1 Capital Fund Qualified, L.p. | Buy | 17,079 | 13.49 | 230,395 |
| 2018-12-04 | Ecor1 Capital Fund Qualified, L.p. | Buy | 54,645 | 13.08 | 714,756 |
| 2018-12-03 | Ecor1 Capital Fund Qualified, L.p. | Buy | 48,182 | 13.97 | 673,102 |
| 2018-11-06 | Wilson Troy Edward (President and CEO) | Option Ex | 26,041 | 4.80 | 124,996 |
| 2017-08-22 | Wilson Troy Edward (President and CEO) | Option Ex | 27,985 | 4.80 | 134,328 |
| 2017-04-21 | Wilson Troy Edward (President and CEO) | Option Ex | 5,000 | 4.80 | 24,000 |
| 2015-11-10 | Malley Thomas (Director) | Buy | 50,000 | 8.00 | 400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KURA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kura Oncology, Inc. (symbol KURA, CIK number 1422143) see the Securities and Exchange Commission (SEC) website.